Back to results
US 2006/0142284 A1Published application
Novel compounds
AssigneeSmithKline Beechan Corporation
InventorJun Tang
Life of this patent
Estimating the term…
Abstract
The present invention relates to anilinopyrazole derivatives, methods for the preparation of such anilinopyrazoles, and use of such anilinopyrazoles in the treatment of certain diseases or conditions. In particular, the present invention relates to a nilinopyrazole derivatives useful as CDK2 inhibitors and use of the anilinopyrazoles in the treatment of disorders mediated by inappropriate CDK2 activity.
Claims21
A compound of the formula I, or a salt, solvate, or a physiologically functional derivative thereof
- in which
- R1 is hydrogen, halogen, —OMe, —OH, —NH2, or —NHSO2CH3, or
- R1 is a radical of the formula
- R2 is hydrogen, chlorine, —OMe, —OH, —NO2, or —NH2.
1 more element
Dependencies are inferred from the claim text.